FDA Inspection 1101231 — Dexcowin Co. Ltd.
The FDA completed an inspection of Dexcowin Co. Ltd. on Jun 6, 2019 in Geumcheon. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 6, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Radiation Control and Health Safety Act
- Location
- Geumcheon (Korea (the Republic of))